WINDROSE HEALTH INVESTORS, LLC
WINDROSE HEALTH INVESTORS, LLC is a Series C+ and buyout fund in the US and Western Europe writing $50M–$500M checks into Healthcare, healthcare-services, value-added-distribution, healthcare-providers and outsourced-services.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, healthcare-services, value-added-distribution, healthcare-providers, outsourced-services
- Check size
- $50M–$500M
- Invests in
- US-wide, Western Europe
- Actively investing
- Yes
- Founded
- 1999
- Assets under management
- $7.01B
- Website
- windrose.com
Thesis
WindRose Health Investors, LLC is a private equity firm specializing in control investments within the healthcare services sector, primarily in the United States and Western Europe. The firm targets profitable, middle-market companies with enterprise values typically between $50 million and $500 million. Their investment strategy focuses on companies that enhance efficiency, deliver value, and leverage new technologies, aligning with thematic shifts in healthcare. WindRose prefers businesses with proven cost-effective solutions and avoids sectors at high risk of disruption. They prioritize growth and operational excellence, taking a conservative approach to debt. The firm has approximately $7.01 billion in AUM, with its latest fund, Fund VII, closing at $2.6 billion.
Common questions
Does WINDROSE HEALTH INVESTORS, LLC invest at the Series C+ stage?
Yes. WINDROSE HEALTH INVESTORS, LLC lists Series C+ and buyout among the stages it invests in.
What check size does WINDROSE HEALTH INVESTORS, LLC write?
WINDROSE HEALTH INVESTORS, LLC writes $50M–$500M checks.
Where does WINDROSE HEALTH INVESTORS, LLC invest?
WINDROSE HEALTH INVESTORS, LLC invests in the US and Western Europe.